BRIDGEBIO PHARMA INC
BBIO·10806X102·US·Common Stock·Healthcare - Biotechnology-Activist
BBIO (BRIDGEBIO PHARMA INC) is held by 208 institutional investors as of Q2 2026. Largest holders: FARALLON CAPITAL MANAGEMENT, L.L.C. ($800.1M), BlackRock, Inc. ($766.2M), VIKING GLOBAL INVESTORS LP ($741M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 109 funds bought BBIO.
Who's Trading
Source dates: Price Aug 31, 2026 · Insiders Aug 20, 2026 · Activists Aug 17, 2026 · Congress Jun 8, 2026
Top Holders
Showing 1-20 of 224
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer